Fate Therapeutics (FATE) Revenue (2012 - 2026)
Fate Therapeutics (FATE) revenue from Sep 30, 2012 to Mar 31, 2026. The TTM Fate Therapeutics (FATE) revenue is $6.32M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Fate Therapeutics (FATE) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -52.59% |
| 3 Years TTM | -64.12% |
| 5 Years TTM | -30.88% |
| 10 Years TTM | +10.03% |
| All Time TTM | +16.18% |
Annual Revenue change of Fate Therapeutics (FATE)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $1.30M | -80.45% |
| 2025 | $6.65M | -51.21% |
| 2024 | $14M | -78.55% |
| 2023 | $64M | -34.03% |
| 2022 | $96M | +72.43% |
| 2021 | $56M | +77.70% |
| 2020 | $31M | +194.29% |
| 2019 | $11M | +125.32% |
| 2018 | $4.74M | +15.33% |
| 2017 | $4.11M | -6.59% |
| 2016 | $4.40M | +81.07% |
| 2015 | $2.43M | N/A |
| 2014 | $0 | -100.00% |
| 2013 | $970K | -63.67% |
| 2012 | $2.67M | +128.21% |
| 2011 | $1.17M | N/A |
| 2010 | $0 | N/A |
| 2009 | $0 | N/A |
| 2008 | $0 | N/A |
Comparison Fate Therapeutics (FATE) five years revenue CAGR with competitors
Fate Therapeutics (FATE) five years revenue CAGR is -30.89%.